James Keenan's profile

James Keenan

CEO

Artenga Inc.

I'm working on

3 years ago

Artenga Inc develops microbubble drug conjugates for BBB delivery

About

Microbubble drug conjugates (MDCs) are used with focused ultrasound (FUS) as a key enabler for non-invasive, targeted, BBB delivery of viral gene therapy, biologics, and chemotherapy. The BBB delivery is verifiable with imaging during the procedure.

Partnering listings

Learn more

Artenga Inc.

Non-invasive targeted CNS delivery using microbubble drug conjugates and focused ultrasound

Artenga Inc. presents a novel CNS delivery platform using microbubble drug conjugates (MDCs) and focused ultrasound (FUS) for targeted, non-invasive treatment, enhancing drug concentration in brain regions and boosting a...

TechnologyIn developmentCompany

James Keenan

CEO

Artenga Inc.

Work experience

Artenga Inc.

CEO

Top industry applications

Neurology & neurological diseasePharmaceuticals and drug delivery

Expertise

AcousticsBiochemical EngineeringBiopharmaceuticsDrug DeliveryGene Therapy

Last updated Sep 2023